EMHA migraine scoring system: A novel, valid, and reliable metric to capture severity, align with patients, and facilitate communication
Patricia Pozo‐Rosich, Edoardo Caronna, Elena Ruiz de la Torre, Messoud Ashina et autres
0 citationsCephalalgia
Patricia Pozo‐Rosich
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
328Publications signalées
14002Citations signalées
3Affiliations récentes
Institutions déclarées
Domaines associés
Migraine and Headache StudiesNeurological Complications and SyndromesTrigeminal Neuralgia and TreatmentsTraumatic Brain Injury ResearchSympathectomy and Hyperhidrosis Treatments
Publications récentes
A multidisciplinary multicentric approach to the identification of predictive biomarkers of response to erenumab – the protocol of the phase 4, European, open-label controlled trial of the BIOMIGA project
Daniele Martinelli, Edoardo Caronna, Hauke Basedau, Rosaria Greco et autres
0 citationsFrontiers in Neurology
Climate Change, Neurological Disorders and Brain Health: To‐Know Concepts and Future Actions by the EAN Environmental Influences in Neurology Task Force
Edoardo Caronna, Sanjay M. Sisodiya, Patricia Pozo‐Rosich, Antonia Boesch et autres
0 citationsEuropean Journal of Neurology
Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?: Insights from the EUREkA cohort
Edoardo Caronna, Rut Mas-de-les-Valls, Gabriella Egeo, Manuel Millán-Vázquez et autres
0 citationsCephalalgia
Efficacy, IHS Guideline Adherence, and Methodological Quality of Noninvasive Neuromodulation Clinical Trials in Migraine and Cluster Headache: A Systematic Review
Javiera Canales‐Rodríguez, Cornelius Angerhöfer, Edoardo Caronna, Bianca Raffaelli et autres
0 citationsEuropean Journal of Neurology
Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis
María Garcés-Pellejero, Marta Torres‐Ferrús, Rut Mas-de-les-Valls, Edoardo Caronna et autres
0 citationsEuropean Journal of Neurology
Evaluation of the effectiveness and safety of anti‐CGRP monoclonal antibodies in patients with migraine and autoimmune diseases: IMMUNO ‐ CGRP study
María Clara García‐Castillo, Álvaro Sierra‐Mencía, Edoardo Caronna, Daniel Toledo‐Alfocea et autres
1 citationHeadache The Journal of Head and Face Pain
Moderate to Severe Acute Migraine Attacks: An Opinion Paper on the Use of Triptans and Triptan-NSAIDs Combinations in Individualized Treatment Plans
Peter J. Goadsby, Alexandra J. Sinclair, Shazia Afridi, Christian Lucas et autres
2 citationsNeurology and Therapy
Combination preventive therapy with onabotulinumtoxinA and atogepant for chronic migraine: A 24-week, prospective, real-world evaluation (SYNERGY study)
Luigi Francesco Iannone, Antonio Russo, Ian Finkelstein, Dineo Seabi et autres
6 citationsCephalalgia
The interplay between migraine, endometriosis and polycystic ovarian syndrome: A systematic review
Laura Gómez‐Dabó, Teresa Jordà-Baleri, Helena Losa-Puig, Edoardo Caronna et autres
6 citationsCephalalgia
Atogepant after anti-CGRP monoclonal antibodies failure in migraine: a multicenter real-world study of effectiveness, safety, persistence and predictors of response
Albert Muñoz‐Vendrell, Sergio Campoy-Díaz, Paloma Valín‐Villanueva, Javier Casas‐Limón et autres
5 citationsThe Journal of Headache and Pain
A phase 4, randomized, double-blind, placebo-controlled trial evaluating the efficacy and tolerability of rimegepant for the prevention of episodic migraine in adults with a history of inadequate response to traditional oral preventive medications
Patricia Pozo‐Rosich, J. Lopez, Paweł Lisewski, Harpreet Seehra et autres
8 citationsCephalalgia
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.